US Broker Ratings

Vaxcyte, Inc. (PCVX) Stock Analysis: Biotech Innovator with Nearly 100% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage biotechnology company, has been making waves in the healthcare sector with its innovative approach to vaccine development. Focused on addressing bacterial infectious diseases, Vaxcyte’s..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Robust Revenue Growth and Strategic Partnerships Fuel Investor Optimism

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a leading entity in the biotechnology sector, is making waves with its promising growth trajectory and innovative product offerings. With a market capitalization of $8.27..

Integer Holdings Corporation (ITGR) Stock Report: Analyst Consensus and Growth Potential

Integer Holdings Corporation (NYSE: ITGR) stands as a pivotal player in the healthcare sector, specifically within the medical devices industry. Headquartered in Plano, Texas, and with a market capitalization of..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Unraveling the 140% Upside Potential

Soleno Therapeutics, Inc. (SLNO) is positioning itself as a significant player in the biotechnology sector with a focus on developing treatments for rare diseases. Headquartered in Redwood City, California, this..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Strong Buy Ratings and 51.25% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands out in the healthcare sector as a dynamic player in the biotechnology industry. With a market capitalization of $4.65 billion, the company has been..

Axsome Therapeutics (AXSM) Stock Analysis: Revenue Growth Soars Amid Biotech Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM) stands as a compelling figure in the biotechnology sector, captivating investor attention with its impressive 63.20% revenue growth amidst the challenges of developing treatments for..

Glaukos Corporation (GKOS) Stock Analysis: A Promising 13.99% Upside in the Medical Devices Sector

Glaukos Corporation (NYSE: GKOS), a leader in the healthcare sector focused on ophthalmic pharmaceuticals and medical technology, is capturing investor attention with an enticing potential upside of 13.99%. As a..

Masimo Corporation (MASI) Stock Analysis: Exploring a 44% Upside Potential in the Healthcare Sector

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector specializing in medical devices, offers an intriguing opportunity for investors seeking exposure to innovative patient monitoring technologies. Headquartered in..

Alkermes plc (ALKS) Stock Analysis: Unveiling a 55% Upside Potential for Investors

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector and a key figure in the specialty and generic drug manufacturing industry, presents a compelling investment opportunity with substantial..

Bausch + Lomb Corporation (BLCO): Investor Outlook on Growth Potential and Strategic Positioning

Bausch + Lomb Corporation (NYSE: BLCO) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $5.87 billion,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 10.44% Upside Potential

Ionis Pharmaceuticals, Inc. (IONS), a prominent player in the biotechnology sector, is making waves in the healthcare industry with its innovative RNA-targeted medicines. With a market capitalization of $12.9 billion,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Potential 3.39% Upside in Biotech Innovation

Investors searching for opportunities in the biotechnology sector might find Akero Therapeutics, Inc. (NASDAQ: AKRO) an intriguing prospect. This South San Francisco-based company, with a market capitalization of $4.5 billion,..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Exploring the 362% Revenue Growth Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the attention of investors with its remarkable 362% revenue growth. As a biopharmaceutical company focused on novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH),..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating a 20% Upside Potential Amidst Healthcare Innovations

Koninklijke Philips N.V. (PHG), a stalwart in the healthcare sector and a pivotal player in the medical devices industry, is capturing investor attention with a potential upside of 20.13%. With..

Guardant Health, Inc. (GH) Stock Analysis: Strong Buy Ratings and 13.5% Upside Potential

Guardant Health, Inc. (NASDAQ: GH) is capturing the attention of investors with its robust growth prospects and strong analyst support. This healthcare company, headquartered in Palo Alto, California, is at..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Powerhouse with 19.66% ROE and Robust Growth Prospects

Krystal Biotech, Inc. (NASDAQ: KRYS), a commercial-stage biotechnology firm, is capturing significant investor attention with its innovative approach to genetic medicine. With a market capitalization of $7.16 billion, this Pittsburgh-based..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: A 19.84% Upside Potential Amid Strong Buy Ratings

Merit Medical Systems, Inc. (NASDAQ: MMSI), a prominent player in the medical instruments and supplies industry, is capturing investor attention with its promising growth prospects. Headquartered in South Jordan, Utah,..

Regencell Bioscience Holdings (RGC) Stock Analysis: Deciphering the Volatility and Growth Potential in Healthcare

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), operates in the healthcare sector, specifically within the drug manufacturing industry with a focus..

The Ensign Group, Inc. (ENSG) Stock Analysis: A Healthcare Leader with 19% Upside Potential

The Ensign Group, Inc. (NASDAQ: ENSG) is making waves in the healthcare sector, earning a reputation as a robust player in the medical care facilities industry. With a market capitalization..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Navigating a 434% Revenue Surge and Strategic Clinical Trials

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering player in the biotechnology sector, is making significant waves with its innovative approach to RNA therapeutics. Based in San Diego, California, Avidity is..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds